013 - A global anti B cell strategy combining Obinutuzumab and Daratumumab for Treatment of Antibody-Mediated Rejection in Pediatric Kidney transplantation

Raja Dandamudi, Washington University in St. Louis School of Medicine, St.Louis, MO, United States; Hannah Foiles, St. Louis Children's Hospital, Jerseyville, IL, United States; Dawn Bunton, St. Louis Children's Hospital, St. Louis, MO, United States; Jennifer Young, St. Louis Children's Hospital, Saint Louis, MO, United States; Patricia Fredrick, St. Louis Children's Hospital, Lake St. Louis, MO, United States; Vikas Dharnidharka, Rutgers, Robert Wood Johnson Medical School, New Brunswick, NJ, United States